[ Price : $8.95]
FDA accepts for review a Myovant Sciences and Pfizer supplemental NDA for Myfembree for managing moderate to severe pain associate...[ Price : $8.95]
Apellis Pharmaceuticals says it plans to file an NDA in the first half of 2022 after reporting top-line results from the Phase 3 D...[ Price : $8.95]
Federal Register notice: FDA seeks nominations for members to serve on the Tobacco Products Scientific Advisory Committee.[ Price : $8.95]
Federal Register notice: CDER announces its Novel Excipient Review Pilot Program and seeks initial proposals by 12/7.[ Price : $8.95]
Azurity Pharmaceuticals recalls one lot of Firvanq (vancomycin hydrochloride for oral solution) 50 mg/mL kit because some products...[ Price : $8.95]
CDER researchers say that more research is needed to determine the most appropriate approaches for statistical and analytical meth...[ Price : $8.95]
FDAs Medical Device Single Audit Program issues a guideline on a five-level nonconformity grading system for medical devices.[ Price : $8.95]
The 13th Annual Sentinel Initiative Virtual Public Workshop 11/8-9 features a keynote address from CDER director Patrizia Cavazzon...